PMID: 24970227

Wang XR, Li C
Decoding F508del misfolding in cystic fibrosis.
Biomolecules. 2014 May 6;4(2):498-509. doi: 10.3390/biom4020498., [PubMed]
Sentences
No. Mutations Sentence Comment
41 ABCC7 p.Arg555Lys
X
ABCC7 p.Arg555Lys 24970227:41:75
status: NEW
view ABCC7 p.Arg555Lys details
This NBD1 conformational defect is fully correctable by revertant mutation R555K [24] or by low-temperature incubation in permissive cell lines, which is accompanied by conformational rescue in other CFTR domains [8]. Login to comment
62 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 24970227:62:0
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 24970227:62:32
status: NEW
view ABCC7 p.Ile539Thr details
I539T/4P refers to the combined I539T and four proline substitutions occurring in chicken CFTR. Login to comment
101 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 24970227:101:36
status: NEW
view ABCC7 p.Ile539Thr details
This is largely accomplished by the I539T substitution and four additional proline substitutions at residues 422, 434, 492, and 534 as the same substitutions made in human F508del CFTR restore its processing, peripheral stability, and channel gating [40]. Login to comment
104 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 24970227:104:64
status: NEW
view ABCC7 p.Ile539Thr details
Molecular dynamics simulation revealed that, in the presence of I539T, proline substitutions stabilize the structurally diverse regions of human F508del NBD1 [40]. Login to comment
110 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24970227:110:101
status: NEW
view ABCC7 p.Gly551Asp details
Food and Drug Administration (FDA) for treatment of 4%-5% of cystic fibrosis patients that carry the G551D substitution mutation [41]. Login to comment